ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

Organ Systems Program Adds Workshops On Lung, Colorectal Cancer

January 26, 1990

In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC

September 4, 1998

In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th

July 27, 1984

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990